BACE1 Inhibitor, Neuroprotective, and Neuritogenic Activities of Melatonin Derivatives
Alzheimer's disease (AD) is a common chronic neurodegenerative disorders. Melatonin (MLT) has been reported to be neuroprotective agent, and its modified structures exhibit potent antioxidant and anti-inflammation activities. Therefore, the activity of MLT and its derivatives against AD was inv...
Saved in:
Main Authors: | Panyada Panyatip (Author), Sarin Tadtong (Author), Emília Sousa (Author), Ploenthip Puthongking (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of <i>N</i>-Amide Substitution on Antioxidative Activities of Melatonin Derivatives
by: Panyada Panyatip, et al.
Published: (2020) -
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease
by: Miguel A. Maia, et al.
Published: (2019) -
Design, in silico and pharmacological evaluation of a peptide inhibitor of BACE-1
by: Renata Boldin, et al.
Published: (2023) -
Bioassay-guided isolation of BACE1 inhibitors from Crataegus pinnatifida
by: Yajuan Zhou, et al.
Published: (2023) -
Cinnamomum verum J. Presl. Bark essential oil: in vitro investigation of anti-cholinesterase, anti-BACE1, and neuroprotective activity
by: Mina Saeedi, et al.
Published: (2022)